Increased level of cAMP-dependent protein kinase in aging human lung fibroblasts
β Scribed by Alice Y.-C. Liu; Zee-Fen Chang; Kuang Yu Chen
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- English
- Weight
- 869 KB
- Volume
- 128
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Endogenous inhibitory mediators such as prostacyclin and nitric oxide keep platelet activation under tight control through the corresponding cGMP and cAMP signaling pathways. Intracellular levels of cAMP and cGMP are regulated by cyclic-nucleotide phosphodiesterases (PDEs). PDE3A (also known as cGMP
CAMP-binding regulatory subunits (RI Or RI1) but share a common catalytic subunit (C) (9,14). RI and RII Medica,
Previous studies have shown that activators of protein kinase C (C kinase) produce synaptic potentiation in the hippocampus. For example, the C kinase activator phorbol dibutyrate has been shown to increase transmitter release in the hippocampus. In addition, a role for C kinase in long-term potenti
Activation of the cAMP signaling pathway in lymphoid cells is known to inhibit cell proliferation of T and B cells as well as cytotoxicity of natural killer (NK) cells. In order to find suitable model systems to study cAMP-mediated processes, we have examined the expression of cAMP-dependent protein
When radioactive polyamines (putrescine or spermidine) were incubated with mammalian cells in tissue culture, the radioactivity was incorporated into cellular proteins via two different metabolic pathways; one is metabolic labeling of an 18,000-dalton protein via hypusine formation, and t h e other